Top Markets
#1 CoW Protocol CoW Protocol +58.99%
#2 EXOD EXOD +56.80%
#3 Glidr Glidr +39.63%
#4 Walrus Walrus +29.20%
#5 Tutorial Tutorial +18.65%
#6 Cysic Cysic +18.33%
#7 The Black Bull The Black Bull +16.56%
#8 Humanity Humanity +16.53%
#9 龙虾 (Lobster) 龙虾 (Lobster) +15.13%
#10 Velvet Velvet +15.00%
Coin of the day
CoW Protocol CoW Protocol
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Relevium Technologies Inc. Relevium Technologies Inc.

Relevium Technologies Inc.

RLLVF
Classifica tra le azioni #37146
Relevium Technologies Inc. operates within the health and wellness sector,... Relevium Technologies Inc. operates within the health and wellness sector, focusing on identifying, assessing, acquiring, and managing various brands and businesses, primarily through e-commerce channels. The company distributes a range of products, including dietary supplements, nutraceuticals, sports nutrition items, and cosmeceuticals, mainly through its Bioganix online brand. It also offers dietary supplements under the LeefyLyfe label and skincare solutions marketed as the Push & Pull System. Additionally, Relevium has developed specialized lines such as Relevium Senior, aimed at older adults for inflammatory conditions affecting joints, heart, and brain, and Relevium Kids, providing nutraceuticals and oral nutritional supplements for children. Headquartered in Montreal, Canada, the company was formerly known as BIOflex Technologies Inc. until it rebranded to Relevium Technologies Inc. in December 2015.
Prezzo delle azioni
$0.006
Ultima sincronizzazione: 2026-08-13
Capitalizzazione di mercato
$1.98M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
CA
Scambia Relevium Technologies Inc. (RLLVF)

Categoria

Healthcare
Ricavi di Relevium Technologies Inc. (RLLVF)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Relevium Technologies Inc., i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Relevium Technologies Inc. da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US